FDA product code QJR: Reagents, 2019-Novel Coronavirus Nucleic Acid

QJR is the FDA product code for reagents, 2019-novel coronavirus nucleic acid. It is a Not classified device, reviewed by the Microbiology panel. Devices under QJR reach the market by PMA; FDA lists no cleared 510(k)s for it. FDA has posted 40 recalls for QJR devices, 17 initiated in the last five years.

Definition

Nucleic acid-based in vitro diagnostic devices for the detection of 2019-novel coronavirus (2019-nCoV) and/or diagnosis of 2019-nCoV infection in human clinical specimens.

Classification

FieldValue
Device nameReagents, 2019-Novel Coronavirus Nucleic Acid
Device classNot classified
Review panelMI — Microbiology
Medical specialtyUnknown
Premarket routePMA

Recalls for QJR devices

40 product recalls in 31 recall events; 17 initiated in the last five years and 21 still open. Most recent: 2025-04-28.

YearRecalls
20205
202118
202211
20233
20241
20252

HCPCS codes with matching descriptors

Text match between the FDA device name and CMS descriptors, not an official crosswalk:

Frequently asked questions

What is FDA product code QJR?

QJR is the FDA product code for reagents, 2019-novel coronavirus nucleic acid. It is a Not classified device, reviewed by the Microbiology panel.

What device class is QJR?

Not classified. Typical premarket route: PMA.

Have QJR devices been recalled?

Yes: 40 product recalls across 31 recall events; the most recent began 2025-04-28.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times